|
ZNF140 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.457200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.744600E-01 |
| Normal-vs-Stage2 |
6.784000E-01 |
| Normal-vs-Stage3 |
6.720600E-01 |
| Normal-vs-Stage4 |
6.772200E-01 |
| Stage1-vs-Stage2 |
8.394400E-01 |
| Stage1-vs-Stage3 |
4.010400E-01 |
| Stage1-vs-Stage4 |
4.431400E-01 |
| Stage2-vs-Stage3 |
4.894800E-01 |
| Stage2-vs-Stage4 |
4.816800E-01 |
| Stage3-vs-Stage4 |
9.971800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.721400E-01 |
| Normal-vs-AfricanAmerican |
4.094200E-01 |
| Normal-vs-Asian |
7.561800E-01 |
| Caucasian-vs-AfricanAmerican |
3.638600E-01 |
| Caucasian-vs-Asian |
8.624800E-01 |
| AfricanAmerican-vs-Asian |
5.651400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.570600E-01 |
| Normal-vs-Female |
3.701800E-01 |
| Male-vs-Female |
1.417440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.338200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.413000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.636000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.196200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.708200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.247800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.037800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.662400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.763800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.233200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.008400E-02 |
| Normal-vs-Grade 2 |
3.681600E-02 |
| Normal-vs-Grade 3 |
1.857820E-01 |
| Normal-vs-Grade 4 |
1.155800E-02 |
| Grade 1-vs-Grade 2 |
5.813200E-01 |
| Grade 1-vs-Grade 3 |
2.944100E-02 |
| Grade 1-vs-Grade 4 |
8.661700E-03 |
| Grade 2-vs-Grade 3 |
2.405500E-04 |
| Grade 2-vs-Grade 4 |
9.61010000000151E-05 |
| Grade 3-vs-Grade 4 |
7.344300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.032100E-02 |
| Normal-vs-ccB subtype |
1.179240E-01 |
| ccA subtype-vs-ccB subtype |
6.442500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.730600E-01 |
| Normal-vs-N1 |
4.905600E-01 |
| N0-vs-N1 |
4.646200E-01 |
|
|
